Literature DB >> 25530115

The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo.

Aviad Keren1, Avner Shemer1, Yehuda Ullmann1, Ralf Paus2, Amos Gilhar3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25530115     DOI： 10.1016/j.jdermsci.2014.11.009

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  6 in total

Review 1.  Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.

Authors:  A Sterkens; J Lambert; A Bervoets
Journal:  Clin Exp Med       Date:  2021-01-01       Impact factor: 3.984

2.  Apremilast in Refractory Alopecia Areata.

Authors:  Andrea Estébanez; Nuria Estébanez; Jose M Martín; Encarna Montesinos
Journal:  Int J Trichology       Date:  2019 Sep-Oct

Review 3.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

Review 4.  Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.

Authors:  Amos Gilhar; Adam G Schrum; Amos Etzioni; Herman Waldmann; Ralf Paus
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

Review 5.  The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.

Authors:  Yael Renert-Yuval; Emma Guttman-Yassky
Journal:  Adv Ther       Date:  2017-06-23       Impact factor: 3.845

Review 6.  Alopecia Areata: An Autoimmune Disease of Multiple Players.

Authors:  Poonkiat Suchonwanit; Chaninan Kositkuljorn; Cherrin Pomsoong
Journal:  Immunotargets Ther       Date:  2021-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.